235 related articles for article (PubMed ID: 17703217)
1. Assessing the delivery efficacy and internalization route of cell-penetrating peptides.
El Andaloussi S; Guterstam P; Langel U
Nat Protoc; 2007; 2(8):2043-7. PubMed ID: 17703217
[TBL] [Abstract][Full Text] [Related]
2. Induction of splice correction by cell-penetrating peptide nucleic acids.
El-Andaloussi S; Johansson HJ; Lundberg P; Langel U
J Gene Med; 2006 Oct; 8(10):1262-73. PubMed ID: 16900561
[TBL] [Abstract][Full Text] [Related]
3. Vectorization of morpholino oligomers by the (R-Ahx-R)4 peptide allows efficient splicing correction in the absence of endosomolytic agents.
Abes S; Moulton HM; Clair P; Prevot P; Youngblood DS; Wu RP; Iversen PL; Lebleu B
J Control Release; 2006 Dec; 116(3):304-13. PubMed ID: 17097177
[TBL] [Abstract][Full Text] [Related]
4. Insights into the cellular trafficking of splice redirecting oligonucleotides complexed with chemically modified cell-penetrating peptides.
Hassane FS; Abes R; El Andaloussi S; Lehto T; Sillard R; Langel U; Lebleu B
J Control Release; 2011 Jul; 153(2):163-72. PubMed ID: 21536086
[TBL] [Abstract][Full Text] [Related]
5. Distinct uptake routes of cell-penetrating peptide conjugates.
Lundin P; Johansson H; Guterstam P; Holm T; Hansen M; Langel U; EL Andaloussi S
Bioconjug Chem; 2008 Dec; 19(12):2535-42. PubMed ID: 19012426
[TBL] [Abstract][Full Text] [Related]
6. Characterization of cellular internalization pathways for CPP-mediated oligonucleotide delivery.
Guterstam P; Andaloussi SE; Langel U
Methods Mol Biol; 2011; 683():219-30. PubMed ID: 21053133
[TBL] [Abstract][Full Text] [Related]
7. Cell-penetrating peptides: mechanism and kinetics of cargo delivery.
Zorko M; Langel U
Adv Drug Deliv Rev; 2005 Feb; 57(4):529-45. PubMed ID: 15722162
[TBL] [Abstract][Full Text] [Related]
8. Enhanced cellular delivery of cell-penetrating peptide-peptide nucleic acid conjugates by photochemical internalization.
Shiraishi T; Nielsen PE
Methods Mol Biol; 2011; 683():391-7. PubMed ID: 21053145
[TBL] [Abstract][Full Text] [Related]
9. Break on through to the other side-biophysics and cell biology shed light on cell-penetrating peptides.
Fischer R; Fotin-Mleczek M; Hufnagel H; Brock R
Chembiochem; 2005 Dec; 6(12):2126-42. PubMed ID: 16254940
[TBL] [Abstract][Full Text] [Related]
10. Application of PepFect peptides for the delivery of splice-correcting oligonucleotides.
Andaloussi SE; Lehto T; Lundin P; Langel U
Methods Mol Biol; 2011; 683():361-73. PubMed ID: 21053143
[TBL] [Abstract][Full Text] [Related]
11. Structural requirements for cellular uptake and antisense activity of peptide nucleic acids conjugated with various peptides.
Wolf Y; Pritz S; Abes S; Bienert M; Lebleu B; Oehlke J
Biochemistry; 2006 Dec; 45(50):14944-54. PubMed ID: 17154532
[TBL] [Abstract][Full Text] [Related]
12. Studying the uptake of cell-penetrating peptides.
Holm T; Johansson H; Lundberg P; Pooga M; Lindgren M; Langel U
Nat Protoc; 2006; 1(2):1001-5. PubMed ID: 17406337
[TBL] [Abstract][Full Text] [Related]
13. A novel anionic dendrimer for improved cellular delivery of antisense oligonucleotides.
Hussain M; Shchepinov M; Sohail M; Benter IF; Hollins AJ; Southern EM; Akhtar S
J Control Release; 2004 Sep; 99(1):139-55. PubMed ID: 15342187
[TBL] [Abstract][Full Text] [Related]
14. Efficient intracellular delivery of nucleic acid pharmaceuticals using cell-penetrating peptides.
Nakase I; Akita H; Kogure K; Gräslund A; Langel U; Harashima H; Futaki S
Acc Chem Res; 2012 Jul; 45(7):1132-9. PubMed ID: 22208383
[TBL] [Abstract][Full Text] [Related]
15. Cell-penetrating peptides-based strategies for the delivery of splice redirecting antisense oligonucleotides.
El Andaloussi S; Said Hassane F; Boisguerin P; Sillard R; Langel U; Lebleu B
Methods Mol Biol; 2011; 764():75-89. PubMed ID: 21748634
[TBL] [Abstract][Full Text] [Related]
16. Recent advances in the use of cell-penetrating peptides for medical and biological applications.
Fonseca SB; Pereira MP; Kelley SO
Adv Drug Deliv Rev; 2009 Sep; 61(11):953-64. PubMed ID: 19538995
[TBL] [Abstract][Full Text] [Related]
17. Cell-penetrating peptides are excluded from the mitochondrial matrix.
Ross MF; Murphy MP
Biochem Soc Trans; 2004 Dec; 32(Pt 6):1072-4. PubMed ID: 15506968
[TBL] [Abstract][Full Text] [Related]
18. Methodological and cellular aspects that govern the internalization mechanisms of arginine-rich cell-penetrating peptides.
Nakase I; Takeuchi T; Tanaka G; Futaki S
Adv Drug Deliv Rev; 2008 Mar; 60(4-5):598-607. PubMed ID: 18045727
[TBL] [Abstract][Full Text] [Related]
19. Stability of cell-penetrating peptide-morpholino oligomer conjugates in human serum and in cells.
Youngblood DS; Hatlevig SA; Hassinger JN; Iversen PL; Moulton HM
Bioconjug Chem; 2007; 18(1):50-60. PubMed ID: 17226957
[TBL] [Abstract][Full Text] [Related]
20. Improved cellular uptake of antisense peptide nucleic acids by conjugation to a cell-penetrating peptide and a lipid domain.
Shiraishi T; Nielsen PE
Methods Mol Biol; 2011; 751():209-21. PubMed ID: 21674333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
